Clinical Trial

Smart Measurement of Circulating Tumor DNA

Name: Smart Measurement of Circulating Tumor DNA — clinical trial record (NCT06989814)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SMART

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this study is to develop a blood-test which can detect colorectal cancer in early stages. Participants will be asked to take an extra blood test, which will be analyzed further in the lab.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-05-16.

Trial Details

NCT Number	NCT06989814
Lead Sponsor	Erasmus Medical Center Collaborators: Dutch Cancer Society, Leiden University Medical Center
Conditions	Colorectal Neoplasms, Colorectal Neoplasms Malignant, Colorectal Neoplasms, Hereditary Nonpolyposis, Hereditary Nonpolyposis Colon Cancer
Enrollment	50 participants
Start Date	2025-05-16
Primary Completion	2026-10-01 (estimated)
Study Completion	2027-02-01 (estimated)
Updated on ClinicalTrials.gov	2025-08-11